Australian Clinical Labs
ACL.AX
#7248
Rank
HK$2.91 B
Marketcap
HK$14.66
Share price
0.00%
Change (1 day)
7.01%
Change (1 year)

Australian Clinical Labs (ACL.AX) - P/B ratio

P/B ratio as of April 2025 : 3.15

According to Australian Clinical Labs's latest financial reports the company has a price-to-book ratio of 0.811004.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Australian Clinical Labs - P/B ratio (from 2022 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-313.675.46%
2023-12-313.4835.92%
2022-12-312.56